FDA news from 02/04 on monoclonal For therapeuti
Post# of 148164
For therapeutics, particularly virus-targeting monoclonal antibodies, we are considering approaches to help expedite drug development in this key area, including discussing appropriate regulatory flexibilities.
https://content.govdelivery.com/accounts/USFD...ns/2bf92eb